Strasbourg, France

Alexandre Detappe

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Dana-Farber-Cancer Institute Inc., Massachusetts Institute of Technology. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alexandre Detappe. Retrieved from https://idiyas.com/inventor/alexandre-detappe-6twuvo1x

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Alexandre Detappe

Introduction

Alexandre Detappe is a notable inventor based in Strasbourg, France. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic strategies. His work focuses on the degradation of dysregulated proteins, which has important implications for treating various diseases.

Latest Patents

Detappe holds a patent for "Proteolysis targeting chimeric molecules (PROTACs) with functional handles and uses thereof." This patent discloses multifunctional compounds, conjugates, macromolecules, and polymers that target dysregulated proteins for degradation. Additionally, it includes methods of preparation, compositions, kits, and methods of use relating to these degraders.

Career Highlights

Throughout his career, Detappe has worked with prestigious institutions such as the Massachusetts Institute of Technology and Dana-Farber Cancer Institute Inc. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.

Collaborations

Detappe has collaborated with notable colleagues, including Jeremiah Allen Johnson and Hung Vanthanh Nguyen. These partnerships have further enhanced his research and innovation in the biotechnology sector.

Conclusion

Alexandre Detappe's work exemplifies the impact of innovative thinking in biotechnology. His contributions to the development of PROTACs represent a significant advancement in therapeutic strategies for targeting dysregulated proteins.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…